Effectiveness of antipsychotic treatment for schizophrenia

6-Month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study

Josep Maria Haro, E. T. Edgell, D. Novick, J. Alonso, L. Kennedy, P. B. Jones, M. Ratcliffe, Alan Breier

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Objective: To present the 6-month outcomes associated with antipsychotic treatment of patients participating in the Schizophrenia Outpatient Health Outcomes (SOHO) study. Method: SOHO is a 3-year, prospective, observational study of the health outcomes associated with antipsychotic treatment in 10 European countries. The study included over 10 000 out-patients who were initiating or changing their antipsychotic medication. Results: Clinical Global Impression (CGI)-severity and quality of life (QOL) scores improved in all treatment cohorts. There was a higher response in the CGI-overall symptoms and in the CGI-schizophrenia positive, negative, cognitive and depressive symptom scales in the olanzapine (Olz) and clozapine (Cloz) cohorts compared with other treatment cohorts. Changes were associated with an improvement in QOL. Conclusion: Patients starting Olz and Cloz tend to have better outcomes at 6 months than patients who start other antipsychotics in actual out-patient clinical practice. The results should be interpreted conservatively because of the non-randomized study design.

Original languageEnglish (US)
Pages (from-to)220-231
Number of pages12
JournalActa Psychiatrica Scandinavica
Volume111
Issue number3
DOIs
StatePublished - Mar 2005

Fingerprint

olanzapine
Antipsychotic Agents
Schizophrenia
Outpatients
Outcome Assessment (Health Care)
Clozapine
Health
Quality of Life
Neurobehavioral Manifestations
Therapeutics
Observational Studies
Prospective Studies
Depression

Keywords

  • Amisulpride
  • Antipsychotic agents
  • Clozapine
  • Olanzapine
  • Quetiapine
  • Risperidone
  • Schizophrenia
  • Treatment outcome

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Effectiveness of antipsychotic treatment for schizophrenia : 6-Month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. / Haro, Josep Maria; Edgell, E. T.; Novick, D.; Alonso, J.; Kennedy, L.; Jones, P. B.; Ratcliffe, M.; Breier, Alan.

In: Acta Psychiatrica Scandinavica, Vol. 111, No. 3, 03.2005, p. 220-231.

Research output: Contribution to journalArticle

Haro, Josep Maria ; Edgell, E. T. ; Novick, D. ; Alonso, J. ; Kennedy, L. ; Jones, P. B. ; Ratcliffe, M. ; Breier, Alan. / Effectiveness of antipsychotic treatment for schizophrenia : 6-Month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. In: Acta Psychiatrica Scandinavica. 2005 ; Vol. 111, No. 3. pp. 220-231.
@article{6145634d1cbe42829e52774915b4609a,
title = "Effectiveness of antipsychotic treatment for schizophrenia: 6-Month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study",
abstract = "Objective: To present the 6-month outcomes associated with antipsychotic treatment of patients participating in the Schizophrenia Outpatient Health Outcomes (SOHO) study. Method: SOHO is a 3-year, prospective, observational study of the health outcomes associated with antipsychotic treatment in 10 European countries. The study included over 10 000 out-patients who were initiating or changing their antipsychotic medication. Results: Clinical Global Impression (CGI)-severity and quality of life (QOL) scores improved in all treatment cohorts. There was a higher response in the CGI-overall symptoms and in the CGI-schizophrenia positive, negative, cognitive and depressive symptom scales in the olanzapine (Olz) and clozapine (Cloz) cohorts compared with other treatment cohorts. Changes were associated with an improvement in QOL. Conclusion: Patients starting Olz and Cloz tend to have better outcomes at 6 months than patients who start other antipsychotics in actual out-patient clinical practice. The results should be interpreted conservatively because of the non-randomized study design.",
keywords = "Amisulpride, Antipsychotic agents, Clozapine, Olanzapine, Quetiapine, Risperidone, Schizophrenia, Treatment outcome",
author = "Haro, {Josep Maria} and Edgell, {E. T.} and D. Novick and J. Alonso and L. Kennedy and Jones, {P. B.} and M. Ratcliffe and Alan Breier",
year = "2005",
month = "3",
doi = "10.1111/j.1600-0447.2004.00450.x",
language = "English (US)",
volume = "111",
pages = "220--231",
journal = "Acta Psychiatrica Scandinavica",
issn = "0001-690X",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Effectiveness of antipsychotic treatment for schizophrenia

T2 - 6-Month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study

AU - Haro, Josep Maria

AU - Edgell, E. T.

AU - Novick, D.

AU - Alonso, J.

AU - Kennedy, L.

AU - Jones, P. B.

AU - Ratcliffe, M.

AU - Breier, Alan

PY - 2005/3

Y1 - 2005/3

N2 - Objective: To present the 6-month outcomes associated with antipsychotic treatment of patients participating in the Schizophrenia Outpatient Health Outcomes (SOHO) study. Method: SOHO is a 3-year, prospective, observational study of the health outcomes associated with antipsychotic treatment in 10 European countries. The study included over 10 000 out-patients who were initiating or changing their antipsychotic medication. Results: Clinical Global Impression (CGI)-severity and quality of life (QOL) scores improved in all treatment cohorts. There was a higher response in the CGI-overall symptoms and in the CGI-schizophrenia positive, negative, cognitive and depressive symptom scales in the olanzapine (Olz) and clozapine (Cloz) cohorts compared with other treatment cohorts. Changes were associated with an improvement in QOL. Conclusion: Patients starting Olz and Cloz tend to have better outcomes at 6 months than patients who start other antipsychotics in actual out-patient clinical practice. The results should be interpreted conservatively because of the non-randomized study design.

AB - Objective: To present the 6-month outcomes associated with antipsychotic treatment of patients participating in the Schizophrenia Outpatient Health Outcomes (SOHO) study. Method: SOHO is a 3-year, prospective, observational study of the health outcomes associated with antipsychotic treatment in 10 European countries. The study included over 10 000 out-patients who were initiating or changing their antipsychotic medication. Results: Clinical Global Impression (CGI)-severity and quality of life (QOL) scores improved in all treatment cohorts. There was a higher response in the CGI-overall symptoms and in the CGI-schizophrenia positive, negative, cognitive and depressive symptom scales in the olanzapine (Olz) and clozapine (Cloz) cohorts compared with other treatment cohorts. Changes were associated with an improvement in QOL. Conclusion: Patients starting Olz and Cloz tend to have better outcomes at 6 months than patients who start other antipsychotics in actual out-patient clinical practice. The results should be interpreted conservatively because of the non-randomized study design.

KW - Amisulpride

KW - Antipsychotic agents

KW - Clozapine

KW - Olanzapine

KW - Quetiapine

KW - Risperidone

KW - Schizophrenia

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=14844309335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14844309335&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0447.2004.00450.x

DO - 10.1111/j.1600-0447.2004.00450.x

M3 - Article

VL - 111

SP - 220

EP - 231

JO - Acta Psychiatrica Scandinavica

JF - Acta Psychiatrica Scandinavica

SN - 0001-690X

IS - 3

ER -